Skip to main content
. Author manuscript; available in PMC: 2018 Feb 14.
Published in final edited form as: J Investig Med. 2017 Jun 8;65(7):1057–1061. doi: 10.1136/jim-2017-000445

Figure 3.

Figure 3

Change of urinary total angiotensinogen/creatinine ratio before and after administration of an SGLT2 inhibitor. Square points are shown as mean. SGLT2 inhibitors tended to decrease total urinary angiotensinogen/creatinine ratio, but these changes are not statistically significant (p=0.19). n.s., not significant; SGLT2, sodium-glucose co-transporter 2.